La ciclosporine topique: Quand et comment l'utiliser ?MILAZZO, Solange; DRIMBEA, Andrei; JANY, Benjamin et al.Pratiques en ophtalmologie. 2014, Vol 8, Num 76, pp 166-169, issn 2106-9735, 4 p.Article

Calcineurin inhibitors in oral medicineAL JOHANI, Khalid A; HEGARTY, Anne M; PORTER, Stephen R et al.Journal of the American Academy of Dermatology. 2009, Vol 61, Num 5, pp 829-840, issn 0190-9622, 12 p.Article

CiclosporinePAUL, C; GARAT, H.Annales de dermatologie et de vénéréologie. 2011, Vol 138, Num 12, pp 836-838, issn 0151-9638, 3 p.Article

Innovative Use of Topical Calcineurin InhibitorsLIN, Andrew N.Dermatologic clinics. 2010, Vol 28, Num 3, issn 0733-8635, 535-545, viii [12 p.]Article

Efficacy of Topical Calcineurin Inhibitors in Lichen PlanusSAMYCIA, Michael; LIN, Andrew N.Journal of cutaneous medicine and surgery. 2012, Vol 16, Num 4, pp 221-229, issn 1203-4754, 9 p.Article

HCV resistance to cyclosporin A does not correlate with a resistance of the NSSA―cyclophilin A interaction to cyclophilin inhibitorsCHATTERJI, Udayan; LIM, Precious; GALLAY, Philippe A et al.Journal of hepatology. 2010, Vol 53, Num 1, pp 50-56, issn 0168-8278, 7 p.Article

Topical tacrolimus has a limited direct effect on ultraviolet B-irradiated keratinocytes: implications for its photocarcinogenic potentialLAN, C.-C. E; YU, H.-S; HUANG, S.-M et al.Clinical and experimental dermatology (Print). 2010, Vol 35, Num 2, pp 173-179, issn 0307-6938, 7 p.Article

Effects of tacrolimus on an organotypic raft-culture model mimicking oral mucosaRAUTAVA, J; PÖLLÄNEN, M; LAINE, M. A et al.Clinical and experimental dermatology (Print). 2012, Vol 37, Num 8, pp 897-903, issn 0307-6938, 7 p.Article

Compatibility of Tacrolimus Ointment with Corticosteroid Ointments of Varying PotenciesPAPPAS, Lisa; KISS, Alex; LEVITT, Jacob et al.Journal of cutaneous medicine and surgery. 2009, Vol 13, Num 3, pp 140-145, issn 1203-4754, 6 p.Article

Effect of Calcineurin Inhibitors on Posaconazole Blood Levels as Measured by the MVista Microbiological AssayZHUANG, David; SMEDEMA, Melinda; LEMONTE, Ann et al.Antimicrobial agents and chemotherapy. 2008, Vol 52, Num 2, pp 730-731, issn 0066-4804, 2 p.Article

Calcineurin inhibitor-free immunosuppression using everolimus (certican) in maintenance heart transplant recipients : 6 months' follow-upROTHENBURGER, Markus; TEERLING, Elisa; BRUCH, Christian et al.The Journal of heart and lung transplantation. 2007, Vol 26, Num 3, pp 250-257, issn 1053-2498, 8 p.Article

Cyclosporine Protects the Heart during Aortic Valve SurgeryCHIARI, Pascal; ANGOULVANT, Denis; OVIZE, Michel et al.Anesthesiology (Philadelphia). 2014, Vol 121, Num 2, pp 232-238, issn 0003-3022, 7 p.Article

Cyclosporine A: de l'immunomodulation à la prévention des lésions d'ischémie-reperfusion = Cyclosporine A: From immunomodulation to prevention of ischemia-reperfusion injuriesGENNAI, S; PISON, C; BRIOT, R et al.Annales françaises d'anesthésie et de réanimation. 2013, Vol 32, Num 12, pp 886-887, issn 0750-7658, 2 p.Article

Long-term efficacy and tolerability of tacrolimus 0.03% ointment in infants: a two-year open-label studyMANDELIN, Johanna M; RUBINS, Andris; REMITZ, Anita et al.International journal of dermatology. 2012, Vol 51, Num 1, pp 104-110, issn 0011-9059, 7 p.Article

Mice Lacking the Calcineurin Inhibitor Rcan2 Have an Isolated Defect of Osteoblast FunctionBASSETT, J. H. Duncan; LOGAN, John G; BOYDE, Alan et al.Endocrinology (Philadelphia). 2012, Vol 153, Num 7, pp 3537-3548, issn 0013-7227, 12 p.Article

Solid lipid nanoparticles prepared by coacervation method as vehicles for ocular cyclosporineBATTAGLIA, L; D'ADDINO, I; PEIRA, E et al.Journal of drug delivery science and technology. 2012, Vol 22, Num 2, pp 125-130, issn 1773-2247, 6 p.Article

Labial Melanotic Macule After Application of Topical Tacrolimus: Two Case ReportsZATTRA, Edoardo; ALBERTIN, Cristiana; BELLONI FORTINA, Anna et al.Acta dermato-venereologica. 2010, Vol 90, Num 5, issn 0001-5555, p. 527Article

Can We Eliminate Both Calcineurin Inhibitors and Steroids?LEBRANCHU, Y.Transplantation proceedings. 2010, Vol 42, Num 9, issn 0041-1345, S25-S28, SUPConference Paper

Effect of calcineurin inhibitors on low-density lipoprotein oxidationCOFAN, F; COFAN, M; CAMPOS, B et al.Transplantation proceedings. 2005, Vol 37, Num 9, pp 3791-3793, issn 0041-1345, 3 p.Conference Paper

Lettre d'information pour le traitement du psoriasis par la ciclosporine orale = Information letter on treatment of psoriasis with oral cyclosporineAnnales de dermatologie et de vénéréologie. 2011, Vol 138, Num 12, pp 863-864, issn 0151-9638, 2 p.Article

Long-Term Maintenance Therapy With Calcineurin Inhibitors: An UpdateCAMPISTOL, J. M.Transplantation proceedings. 2010, Vol 42, Num 9, issn 0041-1345, S21-S24, SUPConference Paper

The Role of Calcineurin Inhibitors in the Management of Lichen SclerosusYESUDIAN, Paul D.American journal of clinical dermatology. 2009, Vol 10, Num 5, pp 313-318, issn 1175-0561, 6 p.Article

Calcineurin Inhibitor Sparing in Renal TransplantationEKBERG, Henrik.Transplantation. 2008, Vol 86, Num 6, pp 761-767, issn 0041-1337, 7 p.Article

Economic Evaluations of Calcineurin Inhibitors in Renal Transplantation : A Literature ReviewMINERS, Alec H; GUIQING YAO; RAFTERY, James et al.PharmacoEconomics (Auckland). 2007, Vol 25, Num 11, pp 935-947, issn 1170-7690, 13 p.Article

Renal graft survival and calcineurin inhibitorWOODWARD, Robert S; KUTINOVA, Andrea; SCHNITZLER, Mark A et al.Transplantation. 2005, Vol 80, Num 5, pp 629-633, issn 0041-1337, 5 p.Article